In this randomized cross-over clinical trial with participants in a lung cancer screening study with CRP levels >2 mg/L, omega 3 significantly lowered CRP levels (by 23%) after 6 months of supplementation compared to their pre-treatment levels. This evidence concerns the gene CRP and lung cancer.